查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1527171

合成生物學市場 - 全球產業規模、佔有率、趨勢、機會和預測，按技術、產品、最終用戶、地區和競爭細分，2019-2029F

Synthetic Biology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Product, By End user, By Region and Competition, 2019-2029F
出版日期: | 出版商: TechSci Research | 英文 187 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2023 年全球合成生物學市場估值為115.2 億美元，預計在預測期內將穩定成長，到2029 年複合年成長率為5.25%。 ，設計和建造新的生物技術零件、設備和系統，正在各個行業迅速發展。隨著基因工程、DNA 定序技術和計算模型的進步，全球合成生物學市場正在經歷指數級成長，徹底改變了從醫療保健、農業到能源和製造業等行業。 CRISPR-Cas9 等基因編輯技術的突破使科學家能夠以前所未有的精度操縱 DNA，從而促進創建用於各種目的的客製化生物體。

市場概況
預測期 2026-2030
2023 年市場規模 115.2億美元
2029 年市場規模 139.9億美元
2024-2029 年複合年成長率 5.25%
成長最快的細分市場 PCR技術
最大的市場 北美洲

主要市場促進因素

對生物基產品的需求不斷成長正在推動全球合成生物市場

擴大醫療保健應用正在推動全球合成生物學市場

主要市場挑戰

監理複雜性

道德和社會問題

主要市場趨勢

技術進步

細分市場洞察

產品洞察

技術洞察

區域洞察

透過創新的生物系統設計，減少生物燃料和生物化學品的負產量。

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：全球合成生物市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術分類（NGS技術、PCR技術、基因組編輯技術、生物加工技術、其他技術）
    • 依產品（寡核苷酸/寡核苷酸庫和合成 DNA、酵素、克隆技術試劑盒、異種核酸、底盤生物體）
    • 按最終用戶（生物技術和製藥公司、學術和政府研究機構、其他）
    • 按地區
    • 按公司分類 (2023)
  • 市場地圖
    • 依技術
    • 按產品分類
    • 按最終用戶
    • 按地區

第 5 章：亞太地區合成生物市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按產品分類
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第 6 章：歐洲合成生物市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按產品分類
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 英國

第 7 章：北美合成生物市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按產品分類
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第 8 章：南美洲合成生物市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按產品分類
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 9 章：中東和非洲合成生物市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按產品分類
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 10 章：市場動態

  • 促進要素
  • 挑戰

第 11 章：市場趨勢與發展

  • 最近的發展
  • 產品發布
  • 併購

第 12 章：全球合成生物學市場：SWOT 分析

第 13 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第14章：競爭格局

  • Bota Biosciences Inc.
  • Codexis, Inc.
  • Enbiotix, Inc.
  • Illumina, Inc.
  • Merck Kgaa (Sigma-Aldrich Co. Llc)
  • Pareto Bio, Inc.
  • Scarab Genomics, Llc
  • Synthego Corporation
  • Synthetic Genomics Inc.
  • Thermo Fisher Scientific, Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 24009

Global Synthetic Biology Market was valued at USD 11.52 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. Synthetic biology, an interdisciplinary field that merges biology and engineering principles to design and construct new biological parts, devices, and systems, is rapidly gaining momentum across various industries. With advancements in genetic engineering, DNA sequencing technologies, and computational modeling, the global synthetic biology market is experiencing exponential growth, revolutionizing industries ranging from healthcare and agriculture to energy and manufacturing. Breakthroughs in gene editing technologies such as CRISPR-Cas9 have empowered scientists to manipulate DNA with unprecedented precision, facilitating the creation of custom-designed organisms for various purposes.

Market Overview
Forecast Period2026-2030
Market Size 2023USD 11.52 Billion
Market Size 2029USD 13.99 Billion
CAGR 2024-20295.25%
Fastest Growing SegmentPCR Technology
Largest MarketNorth America

Key Market Drivers

Increasing Demand for Bio-Based Products is Driving the Global Synthetic Biology Market

In recent years, there has been a notable surge in the demand for bio-based products across various industries worldwide. This burgeoning trend is propelled by a growing awareness of sustainability, environmental concerns, and the need for innovative solutions to address pressing global challenges. At the forefront of this transformative movement is the field of synthetic biology, which offers promising opportunities for the development of novel bio-based products. As a result, the global synthetic biology market is experiencing remarkable growth, driven by the escalating demand for sustainable alternatives to conventional products. With growing concerns about climate change, resource depletion, and pollution, there is a pressing need to transition towards more sustainable practices. Bio-based products derived from renewable sources offer a viable alternative to fossil fuels and petrochemical-based products, reducing greenhouse gas emissions and environmental footprint.

Consumers are becoming more conscious of the environmental and health impacts of the products they use. There is a rising demand for eco-friendly and non-toxic alternatives across various sectors, including cosmetics, personal care, food, and packaging. Synthetic biology enables the production of biodegradable materials, natural flavors, fragrances, and sustainable ingredients, catering to evolving consumer preferences. Governments and regulatory agencies are increasingly supporting the development and commercialization of bio-based products through policies, grants, and incentives. Initiatives aimed at promoting renewable energy, reducing carbon emissions, and fostering innovation in biotechnology are driving investments in synthetic biology research and development. Advances in gene editing techniques, DNA synthesis, and automation are accelerating the pace of innovation in synthetic biology. The emergence of high-throughput screening methods, bioinformatics tools, and computational Modeling enables researchers to design and optimize biological systems with greater precision and efficiency. These technological breakthroughs are unlocking new possibilities for the customization and scale-up of bio-based production processes.

Expanding Applications in Healthcare is Driving the Global Synthetic Biology Market

Synthetic biology, a burgeoning field at the intersection of biology, engineering, and computational science, is revolutionizing the healthcare sector with its innovative applications. This multidisciplinary approach enables scientists to engineer biological systems for diverse purposes, ranging from drug discovery and development to personalized medicine and biomanufacturing. The global synthetic biology market is witnessing significant growth, fueled by expanding applications in healthcare and advancements in genetic engineering technologies. The healthcare industry is experiencing a paradigm shift with the integration of synthetic biology. One of the primary drivers of this transformation is the ability to engineer biological systems to produce valuable therapeutics. Synthetic biology enables the design and synthesis of novel molecules, including proteins, enzymes, and small molecules, for the treatment of various diseases.

Synthetic biology offers unprecedented opportunities for accelerating drug discovery and development processes. By leveraging techniques such as gene editing, pathway engineering, and metabolic engineering, researchers can design and optimize biological systems to produce pharmaceutical compounds with enhanced efficacy and safety profiles. This approach not only expedites the drug development timeline but also facilitates the creation of targeted therapies for complex diseases, such as cancer and genetic disorders. Advancements in synthetic biology are paving the way for personalized medicine, wherein treatments are tailored to individual patients based on their genetic makeup and specific health conditions. Through genome editing technologies like CRISPR-Cas9, scientists can precisely modify DNA sequences associated with disease susceptibility or drug response, enabling the development of customized therapeutic interventions. This personalized approach holds immense potential for improving patient outcomes and minimizing adverse reactions to medications. Synthetic biology is revolutionizing the biomanufacturing sector by offering sustainable and cost-effective alternatives to traditional production methods. Engineered microorganisms, such as bacteria and yeast, serve as cellular factories for the synthesis of pharmaceuticals, biofuels, and industrial chemicals. By optimizing metabolic pathways and genetic circuits, researchers can enhance microbial productivity, streamline production processes, and reduce environmental impact. This transformative approach is driving the development of bio-based manufacturing platforms that promise to revolutionize various industries.

Key Market Challenges

Regulatory Complexity

One of the primary challenges confronting the synthetic biology market is the intricate regulatory landscape. Given the novel nature of synthetic organisms and genetic engineering techniques, regulatory agencies worldwide are tasked with ensuring safety, ethical considerations, and environmental impact assessments. Navigating this complex regulatory framework often requires significant time and resources, posing a barrier to market entry for startups and small enterprises.

Ethical and Societal Concerns

The manipulation of genetic material and the creation of synthetic organisms raise ethical and societal questions regarding the potential consequences of unintended environmental release, biosecurity risks, and equitable access to biotechnological advancements. Public perception and acceptance of synthetic biology applications play a crucial role in shaping regulatory policies and market dynamics. Addressing these concerns necessitates transparent communication, robust ethical frameworks, and engagement with stakeholders across diverse sectors.

Key Market Trends

Technological Advancements

In the ever-evolving landscape of biotechnology, one field stands out for its revolutionary potential - synthetic biology. Harnessing the power of molecular biology, engineering principles, and computational techniques, synthetic biology aims to redesign and construct biological components, systems, and organisms with novel functionalities. As technological advancements continue to accelerate, the global synthetic biology market is experiencing unprecedented growth, fueled by innovation and demand across various sectors. The rapid progression of technologies such as CRISPR-Cas9 gene editing, next-generation sequencing, and high-throughput DNA synthesis has propelled synthetic biology into the forefront of scientific and industrial innovation. These advancements have significantly reduced the cost and time required for genetic manipulation, enabling researchers to engineer biological systems with unprecedented precision and scale.

CRISPR-Cas9, in particular, has revolutionized the field by offering a highly efficient and versatile tool for genome editing. Its applications span from basic research to therapeutic development, agricultural improvement, and industrial biomanufacturing. The ability to precisely edit DNA sequences has opened up new avenues for addressing complex challenges in healthcare, agriculture, and environmental sustainability.

Furthermore, advancements in DNA synthesis technologies have facilitated the rapid assembly of genetic constructs, allowing researchers to design and test novel biological circuits and pathways with ease. High-throughput synthesis platforms have democratized access to custom DNA sequences, empowering scientists and entrepreneurs to explore diverse applications of synthetic biology across industries.

Segmental Insights

Product Insights

Based on the category of Product, Oligonucleotide/Oligo Pools and Synthetic DNA emerged as the dominant segment in the global market for Synthetic Biology in 2023. Oligonucleotide/oligo pools and synthetic DNA serve as the building blocks of synthetic biology. These technologies enable researchers to design, modify, and synthesize DNA sequences with precision and efficiency previously unimaginable. Oligo pools consist of a collection of short, single-stranded DNA or RNA molecules that can be customized to contain specific sequences of interest. Synthetic DNA, on the other hand, involves the laboratory synthesis of entire genes or genomes. Oligo pools and synthetic DNA offer unparalleled customization and flexibility, allowing researchers to tailor DNA sequences to meet their exact specifications. This level of control is crucial for designing biological systems with desired functionalities, such as gene editing, protein expression, and pathway optimization. Oligo pools and synthetic DNA find applications across a wide range of industries, including healthcare, agriculture, energy, and environmental remediation. From engineering microbial strains for biofuel production to designing personalized therapeutics for precision medicine, the potential applications of these technologies are virtually limitless.

Technology Insights

The PCR Technology segment is projected to experience rapid growth during the forecast period. The global synthetic biology market has experienced exponential growth in recent years, with PCR technology playing a vital role in driving this expansion. PCR-based techniques are extensively used in synthetic biology research, enabling scientists to construct, modify, and analyze DNA sequences with unparalleled accuracy. This has led to the development of novel bio-based products, therapeutic solutions, and sustainable technologies, driving the market forward. One of the key reasons for PCR's dominance in the synthetic biology market is its versatility and flexibility. PCR can be adapted to various applications, including gene synthesis, DNA assembly, and site-directed mutagenesis, making it an indispensable tool for researchers across different disciplines. Additionally, advancements in PCR technology, such as real-time PCR and digital PCR, have further expanded its utility, allowing for precise quantification and analysis of DNA sequences.

Regional Insights

North America boasts a robust ecosystem of research institutions, universities, and biotechnology companies dedicated to advancing synthetic biology. Leading academic institutions such as MIT, Harvard, and Stanford have established renowned research programs and interdisciplinary collaborations in synthetic biology. Additionally, the region is home to prominent biotech hubs like the San Francisco Bay Area, Boston-Cambridge corridor, and San Diego, fostering innovation and entrepreneurship in the field.

negative production of biofuels and biochemicals through innovative biosystems design.

Key Market Players

Bota Biosciences Inc.

Codexis, Inc.

Enbiotix, Inc.

Illumina, Inc.

Merck Kgaa (Sigma-Aldrich Co. Llc)

Pareto Bio, Inc.

Scarab Genomics, Llc

Synthego Corporation

Synthetic Genomics Inc.

Thermo Fisher Scientific, Inc.

Report Scope:

In this report, the Global Synthetic Biology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Synthetic Biology Market, By Technology:

    NGS Technology PCR Technology Genome Editing Technology Bioprocessing Technology Other Technologies

Synthetic Biology Market, By Product:

    Oligonucleotide/Oligo Pools and Synthetic DNA Enzymes Cloning Technologies Kits Xeno-Nucleic Acids Chassis Organism

Synthetic Biology Market, By End User:

    Biotechnology and Pharmaceutical Companies Academic and Government Research Institutes Others

Synthetic Biology Market, By Region:

    North America
    • United States
    • Canada
    • Mexico
    Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
    Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    South America
    • Brazil
    • Argentina
    • Colombia
    Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Synthetic Biology Market.

Available Customizations:

Global Synthetic Biology market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Synthetic Biology Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Technology (NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, Other Technologies)
    • 4.2.2. By Product (Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, Chassis Organism)
    • 4.2.3. By End user (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Others)
    • 4.2.4. By Region
    • 4.2.5. By Company (2023)
  • 4.3. Market Map
    • 4.3.1. By Technology
    • 4.3.2. By Product
    • 4.3.3. By End user
    • 4.3.4. By Region

5. Asia Pacific Synthetic Biology Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology
    • 5.2.2. By Product
    • 5.2.3. By End user
    • 5.2.4. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Synthetic Biology Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Technology
        • 5.3.1.2.2. By Product
        • 5.3.1.2.3. By End user
    • 5.3.2. India Synthetic Biology Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Technology
        • 5.3.2.2.2. By Product
        • 5.3.2.2.3. By End user
    • 5.3.3. Australia Synthetic Biology Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Technology
        • 5.3.3.2.2. By Product
        • 5.3.3.2.3. By End user
    • 5.3.4. Japan Synthetic Biology Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Technology
        • 5.3.4.2.2. By Product
        • 5.3.4.2.3. By End user
    • 5.3.5. South Korea Synthetic Biology Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Technology
        • 5.3.5.2.2. By Product
        • 5.3.5.2.3. By End user

6. Europe Synthetic Biology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Product
    • 6.2.3. By End user
    • 6.2.4. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Synthetic Biology Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By End user
    • 6.3.2. Germany Synthetic Biology Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By End user
    • 6.3.3. Spain Synthetic Biology Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By End user
    • 6.3.4. Italy Synthetic Biology Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Technology
        • 6.3.4.2.2. By Product
        • 6.3.4.2.3. By End user
    • 6.3.5. United Kingdom Synthetic Biology Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Technology
        • 6.3.5.2.2. By Product
        • 6.3.5.2.3. By End user

7. North America Synthetic Biology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Product
    • 7.2.3. By End user
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Synthetic Biology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By End user
    • 7.3.2. Mexico Synthetic Biology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By End user
    • 7.3.3. Canada Synthetic Biology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By End user

8. South America Synthetic Biology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Product
    • 8.2.3. By End user
    • 8.2.4. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Synthetic Biology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By End user
    • 8.3.2. Argentina Synthetic Biology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By End user
    • 8.3.3. Colombia Synthetic Biology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By End user

9. Middle East and Africa Synthetic Biology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Product
    • 9.2.3. By End user
    • 9.2.4. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Synthetic Biology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By End user
    • 9.3.2. Saudi Arabia Synthetic Biology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By End user
    • 9.3.3. UAE Synthetic Biology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By End user

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Synthetic Biology Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Bota Biosciences Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Product & Services
    • 14.1.4. Financials (In case of listed)
    • 14.1.5. Recent Developments
    • 14.1.6. SWOT Analysis
  • 14.2. Codexis, Inc.
  • 14.3. Enbiotix, Inc.
  • 14.4. Illumina, Inc.
  • 14.5. Merck Kgaa (Sigma-Aldrich Co. Llc)
  • 14.6. Pareto Bio, Inc.
  • 14.7. Scarab Genomics, Llc
  • 14.8. Synthego Corporation
  • 14.9. Synthetic Genomics Inc.
  • 14.10. Thermo Fisher Scientific, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer